Grant: Alliance Grants
Institut national de la recherche scientifique
$113,050.00
Recombinant proteins as a platform technology for multi-serotype S. suis vaccines
FY 2024-25
Summary
Despite the economic risk that Streptococcus suis represents for the pig industry, no commercial vaccine is yet available in Canada or elsewhere in the world. The lack of effective vaccines against this pathogen constitutes an economic burden for the Canadian pork industry (3rd largest agri-food sector in Canada). The project aims to combine the expertise of three partners (INRS, NRC-CNRC and EVAH Corp.) to identify and develop new sustainable vaccine solutions to prevent swine infections by Streptococcus suis.
Program
Alliance Grants
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
581556-2023
Name nom
Calmettes, Charles C
Department département
INRS-Institut Armand-Frappier, Centre
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
113050
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Recombinant proteins as a platform technology for multi-serotype S. suis vaccines
Keywords
biotechnology; protein engineering; recombinant proteins; streptococcus suis; structure-based-vaccine-design; veterinary vaccine
Application summary
Despite the economic risk that Streptococcus suis represents for the pig industry, no commercial vaccine is yet available in Canada or elsewhere in the world. The lack of effective vaccines against this pathogen constitutes an economic burden for the Canadian pork industry (3rd largest agri-food sector in Canada). The project aims to combine the expertise of three partners (INRS, NRC-CNRC and EVAH Corp.) to identify and develop new sustainable vaccine solutions to prevent swine infections by Streptococcus suis.
